Niox trading in line with expectations
![Niox Group | Sharecast graphic / Josh White dl niox group plc niox health care healthcare medical equipment and services medical equipment ftse aim 100 logo 20230926 1339](https://img4.s3wfg.com/web/img/images_uploaded/9/7/dl--niox-group-plc--niox--health-care--healthcare--medical-equipment-and-services--medical-equipment--ftse-aim-100--logo--20230926-1339_620x350.jpg)
Niox Group
69.00p
16:35 21/06/24
Asthma-focussed medical device company Niox said in an update on Wednesday that it continued to perform strongly in the year to date, meeting management expectations.
FTSE AIM 100
3,724.55
17:14 21/06/24
FTSE AIM 50
4,228.11
17:14 21/06/24
FTSE AIM All-Share
772.57
17:14 21/06/24
Health Care Equipment & Services
11,404.92
17:05 21/06/24
The AIM-traded firm, which was holding its annual general meeting, noted that it settled returns claims totaling £0.4m in January, related to its discontinued business operations.
As of 30 April, the unaudited cash balance for Niox was £23.7m, up from £19.9m at the end of December 2023, with the company maintaining a debt-free status.
Niox said it would provide a trading update for the six months ending 30 June in mid-July.
At 1240 BST, shares in Niox Group were up 1.1% at 73.4p.
Reporting by Josh White for Sharecast.com.